Drawn out of retirement by a former CIA colleague, Max Pauling is asked to investigate a powerful American pharmaceutical firm that may be using a German company as a front to avoid the U.S.
scientific embargo of Cuba and finds himself caught in the crossfire of a scheme to seize control of some groundbreaking medical research. Reprint.